» Articles » PMID: 26396502

Interventional Tools to Improve Medication Adherence: Review of Literature

Overview
Date 2015 Sep 24
PMID 26396502
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Medication adherence and persistence is recognized as a worldwide public health problem, particularly important in the management of chronic diseases. Nonadherence to medical plans affects every level of the population, but particularly older adults due to the high number of coexisting diseases they are affected by and the consequent polypharmacy. Chronic disease management requires a continuous psychological adaptation and behavioral reorganization. In literature, many interventions to improve medication adherence have been described for different clinical conditions, however, most interventions seem to fail in their aims. Moreover, most interventions associated with adherence improvements are not associated with improvements in other outcomes. Indeed, in the last decades, the degree of nonadherence remained unchanged. In this work, we review the most frequent interventions employed to increase the degree of medication adherence, the measured outcomes, and the improvements achieved, as well as the main limitations of the available studies on adherence, with a particular focus on older persons.

Citing Articles

Medication adherence in the curricula of future European physicians, pharmacists and nurses - a cross-sectional survey.

Gottlieb H, Seghers L, Leiva-Fernandez F, Ghiciuc C, Hafez G, Herdeiro M BMC Med Educ. 2025; 25(1):339.

PMID: 40045247 PMC: 11881433. DOI: 10.1186/s12909-025-06909-1.


Correlation Between Objective Habit Metrics and Objective Medication Adherence: Retrospective Study of 15,818 Participants From Clinical Studies.

Pironet A, Phillips L, Vrijens B Interact J Med Res. 2025; 14:e63987.

PMID: 39914802 PMC: 11843050. DOI: 10.2196/63987.


Nurse-led medication self-management intervention in the improvement of medication adherence in adult patients with multi-morbidity: A Protocol for a Feasibility Randomized controlled trial.

Singh K, Joy G, Al Bulushi A, Alomari A, Mannethodi K, Kunjavara J Glob Epidemiol. 2025; 9:100184.

PMID: 39897388 PMC: 11786918. DOI: 10.1016/j.gloepi.2025.100184.


Adherence, Fears, and Beliefs about Biologic Drugs in Rheumatoid Arthritis Patients: A North African Pilot Study.

Boussaid S, Hannech E, Rekik S, Rahmouni S, Zouaoui K, Abbes M Mediterr J Rheumatol. 2025; 35(4):623-633.

PMID: 39886288 PMC: 11778605. DOI: 10.31138/mjr.200823.afa.


Stakeholder perspectives on facilitators and barriers to implementing a zero-dollar copay program for chronic conditions study.

Winberg D, Nauman E, Shi L, Mohundro B, Louis K, Price-Haywood E Health Res Policy Syst. 2025; 23(1):6.

PMID: 39762862 PMC: 11702045. DOI: 10.1186/s12961-024-01278-5.


References
1.
Morris L, Schulz R . Patient compliance--an overview. J Clin Pharm Ther. 1992; 17(5):283-95. DOI: 10.1111/j.1365-2710.1992.tb01306.x. View

2.
Xiong T, Li J, Mao J, Xu J . Medication-related problems among community-dwelling older adults after recent hospital discharge in mainland China. Nurs Res. 2014; 63(6):439-45. DOI: 10.1097/NNR.0000000000000064. View

3.
Vergouwen A, Bakker A, Katon W, Verheij T, Koerselman F . Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 2004; 64(12):1415-20. DOI: 10.4088/jcp.v64n1203. View

4.
Korsch B, GOZZI E, Francis V . Gaps in doctor-patient communication. 1. Doctor-patient interaction and patient satisfaction. Pediatrics. 1968; 42(5):855-71. View

5.
Fagerlin A, Zikmund-Fisher B, Nair V, Derry H, McClure J, Greene S . Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid. Breast Cancer Res Treat. 2009; 119(3):613-20. PMC: 3736824. DOI: 10.1007/s10549-009-0618-4. View